Tag Archives: Oncaspar

April, 2018

  • 16 April

    Shire Sells Oncology Business to Servier for $2.4 Billion

    Dublin, Ireland – April 16, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) the leading global biotechnology company focused on rare diseases announces today that it has entered into a definitive agreement with Servier S.A.S. (“Servier”) to sell its Oncology business for $2.4 billion. Shire’s Oncology business includes in-market products ONCASPAR® …

May, 2015